Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
Environ Geochem Health ; 41(2): 1037-1053, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30276587

ABSTRACT

An assortment of organic material can leach from lignite (low-rank coal) in water, and the water-soluble fraction from lignite has been associated with adverse health effects in areas of the Balkans. Recent efforts have been made to evaluate this hypothesis in other areas where lignite is in contact with groundwater like in the U.S. Gulf Coast region. In this study, five Gulf Coast lignite samples were extracted with water, and the water-soluble portion of the coal was then characterized by total organic carbon, UV-Vis spectroscopy, and gas chromatography/mass spectrometry. Additionally, human kidney cells (HK-2) were exposed to water-soluble extracts of Gulf Coast lignite to assess toxicity. Cell viability was measured, and a dose-response curve was used to generate IC50 values that ranged from 490 to 3000 ppm. The most toxic extract (Dolet Hills) was from Louisiana where lignite-derived organic material has been previously linked to high incidence of renal pelvic cancer. Concentrations of nephrotoxic metals (As, Cd, Co, Cu, Hg, Pb, V, Zn) were screened and were below those considered toxic to renal cells. We conclude that leachates from lignite do indeed have toxic affects on cultured human renal cells. Although the IC50 values are higher than the concentration of organic matter in the local groundwater, typically < 5 ppm, the effects of long-term low-level exposure is not known.


Subject(s)
Coal/toxicity , Kidney/drug effects , Carbon/analysis , Cell Line , Coal/analysis , Gas Chromatography-Mass Spectrometry , Humans , Kidney/cytology , Mercury/analysis , Mercury/toxicity , Metals/analysis , Metals/toxicity , Spectrophotometry, Ultraviolet , Toxicity Tests/methods , United States , Water/chemistry
3.
Ann Oncol ; 26(5): 838-847, 2015 May.
Article in English | MEDLINE | ID: mdl-25411417

ABSTRACT

Thymic epithelial tumors (TETs) are rare primary mediastinal tumors arising from thymic epithelium. Their rarity and complexity hinder investigations of their causes and therapy development. Here, we summarize the existing knowledge regarding medical treatment of these tumors, and thoroughly review the known genetic aberrations associated with TETs and the present status of potential biological treatments. Epidermal growth factor receptor (EGFR), stem-cell factor receptor, insulin-like growth factor-1 receptor (IGF1R), and vascular endothelial growth factors (VEGF-A, VEGF-B, and VEGF-2) are overexpressed in TETs. EGFR overexpression in TETs is associated with higher stage, and IGF1R overexpression has poor prognostic value. Data indicate that anti-IGF1R monoclonal antibodies, and inhibitors of angiogenesis, somatostatin receptors, histone deacetylase, mammalian target of rapamycin, and cyclin-dependent kinases may be active against TETs. Continued investigations in this field could lead to advancement of targeted and biological therapies for TETs.


Subject(s)
Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biological Products/therapeutic use , Biomarkers, Tumor/antagonists & inhibitors , Molecular Targeted Therapy , Neoplasms, Glandular and Epithelial/drug therapy , Signal Transduction/drug effects , Thymus Neoplasms/drug therapy , Animals , Antineoplastic Agents/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Biological Products/adverse effects , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Humans , Molecular Targeted Therapy/adverse effects , Neoplasm Staging , Neoplasms, Glandular and Epithelial/genetics , Neoplasms, Glandular and Epithelial/metabolism , Neoplasms, Glandular and Epithelial/pathology , Thymus Neoplasms/genetics , Thymus Neoplasms/metabolism , Thymus Neoplasms/pathology , Treatment Outcome
4.
Br J Dermatol ; 161(2): 237-48, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19438433

ABSTRACT

BACKGROUND: Interleukin (IL-6) and transforming growth factor (TGF)-beta have been shown to play a role in skin development and maintenance. OBJECTIVES: A link between these two cytokines has yet to be identified and therefore in this study we investigated the modulation of TGF-beta1 and TGF-beta type 2 receptor (TGF-betaR2) by IL-6 in skin. METHODS: An IL-6 knockout (IL-6KO) fibroblast-populated lattice model and intradermal injections of IL-6 into unwounded IL-6KO mice were used to investigate the direct effects of IL-6 treatment on TGF-beta and TGF-betaR2 expression and to determine the signalling mechanism. In addition, IL-6KO and C57BL/6 control mice were wounded by a 4-mm punch biopsy to monitor expression of TGF-beta1 and TGF-betaR2 within a wound over time. The expression of TGF-beta1 and TGF-betaR2 was assessed by real-time quantitative polymerase chain reaction, enzyme-linked immunosorbent assay and immunohistology. RESULTS: Recombinant IL-6 treatment of IL-6KO lattices and intradermal injections of IL-6 showed a significant induction of TGF-beta1 mRNA and protein, with TGF-beta1 expression localized in the dermis, while TGF-betaR2 expression was primarily in the epidermis in IL-6KO mice. During healing, the expression of TGF-beta1 and TGF-betaR2 mRNA was significantly greater in unwounded and 7-day-old wounds from wild-type mice; however, protein expression did not differ. Treatment with signal transduction inhibitors indicated that IL-6 modulates TGF-beta through a mitogen-activated protein kinase/extracellular signal-regulated kinase (Mapk/Erk)-dependent mechanism. CONCLUSION: These studies indicate that IL-6 has the ability to modulate the expression of TGF-beta and TGF-betaR2 to varying degrees in the skin, which may provide a possible mechanism for defining the role of IL-6 in skin maintenance and a new association of IL-6 with TGF-beta in pathologies associated with fibrosis.


Subject(s)
Fibroblasts/metabolism , Interleukin-6/physiology , Protein Serine-Threonine Kinases/metabolism , Receptors, Transforming Growth Factor beta/metabolism , Skin/metabolism , Transforming Growth Factor beta/metabolism , Animals , Animals, Newborn , Immunohistochemistry , Interleukin-6/deficiency , Interleukin-6/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptor, Transforming Growth Factor-beta Type II , Skin/injuries , Skin/pathology , Transforming Growth Factor beta/genetics
5.
Br J Dermatol ; 156(6): 1163-71, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17441960

ABSTRACT

BACKGROUND: Interleukin-6-deficient (IL-6KO) mice display significantly delayed cutaneous wound healing characterized by decreased re-epithelialization, granulation tissue and wound closure. Dermal fibroblasts are one of the principal cell types found in granulation tissue and mediate numerous processes during healing. OBJECTIVES: To investigate the effects that IL-6 might have on granulation tissue formation and fibroblast motility. As fibroblast motility is associated with matrix metalloproteinase (MMP) activity, the expression of MMP-2 and the tissue inhibitors of metalloproteinase (TIMP)-1 and -2 were assessed. METHODS: Punch biopsies (4 mm) were performed in the skin of IL-6KO and C57BL/6 mice. The expression of MMP-2, TIMP-1 and -2 in wound tissue was monitored over time. Cellular infiltration and granulation tissue formation was monitored by subcutaneous implantation of polyvinyl alcohol (PVA) sponges. A free-floating collagen lattice model was also used to investigate the direct effects of IL-6 treatment on isolated IL-6KO fibroblasts. The expression of MMP-2, and the inhibitors TIMP-1 and -2, were assessed via real-time quantitative polymerase chain reaction and enzyme-linked immunosorbent assay. RESULTS: IL-6KO wounds showed impaired granulation tissue formation 5 days postwounding and fewer fibroblasts had populated the PVA matrices 7 days after implantation in IL-6KO mice compared with wild-type C57BL/6. The mRNA and protein expression of MMP-2 and TIMP-2 mRNA was increased in IL-6KO mice compared with wild-type mice beyond 1 day postwounding, while the expression of TIMP-1 mRNA was transiently higher in IL-6KO only 3 days postwounding. Treatment of collagen lattices with various concentrations of rmIL-6 again showed a dose-response decrease in mRNA and protein expression of MMP-2 and TIMP-2 protein expression, compared with saline control, while TIMP-1 did not appear to be significantly modulated. CONCLUSIONS: These results indicate that IL-6 influences the function of fibroblasts in wounds, and one mechanism of this regulation may be through the modulation of MMP-2 and TIMP proteins.


Subject(s)
Fibroblasts/physiology , Interleukin-6/therapeutic use , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 2/metabolism , Tissue Inhibitor of Metalloproteinase-1/metabolism , Tissue Inhibitor of Metalloproteinase-2/metabolism , Animals , Cell Movement/drug effects , Granulation Tissue/cytology , Granulation Tissue/metabolism , Interleukin-6/deficiency , Interleukin-6/genetics , Mice , Mice, Inbred C57BL , Wound Healing
6.
Cell Biol Toxicol ; 21(5-6): 233-46, 2005.
Article in English | MEDLINE | ID: mdl-16323059

ABSTRACT

Limited information is available regarding the development of systemic organ stress by dermal exposure to JP-8 fuel. In this study, the systemic stress potential of this fuel is evaluated in a rat model subjected to dermal applications of JP-8 for 7 days at 300 microl per day. Tissue histology indicated that JP-8 induces morphological alterations that suggest that tissue stress in the heart is more substantial than stress in the kidney and liver. Immunoblot analysis of tissues revealed increased levels of the inducible heat shock protein 70 (HSP70) in the heart, kidney, and liver after this dermal JP-8 exposure. This exposure also leads to increased levels of heme oxygenase-1 (HO-1/HSP3) in the liver. Additionally during this exposure, a negative regulator of inflammation, IkappaBalpha (inhibitor of NF-kappaB), was increased in the liver, slightly increased in the kidney, and not increased in the heart. Two regions of the rat brain were also examined and HSP70 and IkappaBalpha were increased in the cerebellum but not significantly increased in the cortex. This study indicates dermal JP-8 exposure causes systemic alterations that are associated with cytoprotective activities (e.g., in the liver) as well as potentially toxic mechanisms (heart and kidney).


Subject(s)
Heart/drug effects , Hydrocarbons/toxicity , Administration, Cutaneous , Animals , Brain Chemistry , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/metabolism , HSP70 Heat-Shock Proteins/metabolism , Heat Shock Transcription Factors , Heme Oxygenase (Decyclizing)/metabolism , Hydrocarbons/administration & dosage , I-kappa B Proteins/metabolism , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Molecular Weight , Myocardium/metabolism , Myocardium/pathology , NF-KappaB Inhibitor alpha , Phosphorylation , Rats , Rats, Long-Evans , Transcription Factors/chemistry , Transcription Factors/metabolism
7.
Toxicol Appl Pharmacol ; 177(2): 112-20, 2001 Dec 01.
Article in English | MEDLINE | ID: mdl-11740910

ABSTRACT

Hepatic expression of the proinflammatory cytokine tumor necrosis factor-alpha (TNFalpha) occurs in many acute and chronic liver diseases, as well as following exposure to hepatotoxic chemicals, and is believed to help influence both the damage and repair processes that occur following these insults by regulating additional mediators. We examined the role of TNFalpha in transgenic mice deficient in TNF receptors (TNFR) utilizing carbon tetrachloride (CCl(4)) as a model hepatotoxic agent that allowed for the evaluation of necrosis, inflammation, and fibrosis. Hepatocyte damage, as evident by local areas of liver necrosis and elevated levels of serum transaminase, occurred to a similar degree in wild-type and TNFR-deficient knockout (KO) mice following acute exposure to CCl(4). In contrast, the inflammatory response, manifested as an inflammatory cell influx, as well as induction of chemokines and adhesion molecules that occurred in wild-type mice following treatment with CCl(4), was not as evident in TNFR-KO mice. This response was associated primarily with type-1 (TNFR1) rather than type-2 (TNFR2) receptor responses. Liver fibrosis resulting from chronic CCl(4) exposure was also markedly dependent upon TNFalpha as demonstrated by almost a complete histological absence of fibrosis in TNFR-deficient mice. This was further supported by marked reductions in procollagen and transforming growth factor beta synthesis in TNFR-deficient mice. Taken together, these results indicate that TNFalpha is responsible for regulating products that induce inflammation and fibrosis but not direct hepatocyte damage in CCl(4)-induced hepatotoxicity.


Subject(s)
Carbon Tetrachloride/toxicity , Chemical and Drug Induced Liver Injury/etiology , Liver Cirrhosis/chemically induced , Liver/drug effects , Receptors, Tumor Necrosis Factor/antagonists & inhibitors , Tumor Necrosis Factor-alpha/immunology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Chemical and Drug Induced Liver Injury/immunology , Fibrillar Collagens/metabolism , Gene Expression Regulation , Histocytochemistry , Intercellular Adhesion Molecule-1/analysis , Intercellular Adhesion Molecule-1/biosynthesis , Liver/pathology , Liver Cirrhosis/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Peroxidase/metabolism , Random Allocation , Receptors, Tumor Necrosis Factor/genetics , Reverse Transcriptase Polymerase Chain Reaction
8.
Cytokine ; 15(6): 328-36, 2001 Sep 21.
Article in English | MEDLINE | ID: mdl-11594800

ABSTRACT

Dermal wounding is accompanied by inflammation and the resulting proinflammatory cytokines, including interleukin (IL)-6, are thought to play an important role in the repair process. IL-6 is produced by normal human keratinocytes to various dermatological diseases and we have recently shown it is also required for normal wound repair. However, neither the events responsible for its induction nor its role in repair have been clearly identified. Using a recently developed in vitro wounding model, we demonstrate that IL-6 mRNA is expressed and immunoreactive IL-6 is released from cultures of human epidermal keratinocytes (NHEKs) following wounding. The transcription factors, NF kappa B and NF-IL-6 (C/EBP beta), which coordinately help regulate IL-6 expression, were activated following wounding and preceded the appearance of IL-6. Addition of IL-1 alpha to NHEK cultures increased IL-6 production and activated NF kappa B and C/EBP beta. Addition of the IL-1 alpha receptor antagonist inhibited both IL-6 mRNA expression and the transcription factors following wounding. Immunoreactive IL-1 alpha was detected in the medium following wounding in the absence of new message. Furthermore, addition of IL-6 to NHEK cultures decreased the expression of keratins 1 and 10, differentiation markers of keratinocytes, while proliferation was not affected. Taken together, these data indicate that constitutive keratinocyte-derived IL-1 alpha is a stimulus for IL-6 production in wounded epidermis, the response involves NF kappa B and C/EBP beta transcription factors, and IL-6 may be associated with modulation of keratinocyte differentiation rather than proliferation.


Subject(s)
Epithelial Cells/metabolism , Interleukin-6/metabolism , Interleukin-6/physiology , Keratinocytes/metabolism , Wound Healing , Adult , CCAAT-Enhancer-Binding Protein-beta/metabolism , Cell Differentiation , Cell Division/drug effects , Cells, Cultured , Cytokines/antagonists & inhibitors , DNA/metabolism , Enzyme Activation , Enzyme-Linked Immunosorbent Assay , Female , Humans , Interleukin-1/biosynthesis , Interleukin-6/biosynthesis , Keratins/biosynthesis , NF-kappa B/metabolism , Protein Binding , RNA/metabolism , RNA, Messenger/metabolism , Receptors, Interleukin-1/antagonists & inhibitors , Reverse Transcriptase Polymerase Chain Reaction , Skin/cytology , Time Factors , Transcription, Genetic
9.
J Interferon Cytokine Res ; 21(8): 603-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11559438

ABSTRACT

It has been postulated that the inflammatory response that occurs after cutaneous wounding is a prerequisite for healing and that inflammatory cytokines, such as interleukin-6 (IL-6) are involved in this process. We showed previously that IL-6-deficient mice display delayed wound healing, which could be reversed by administration of a murine IL-6 expression plasmid or recombinant murine IL-6 (rMuIL-6). In the present study, we observed that delayed cutaneous wound healing, which occurs as a result of glucocorticoid-induced immunosuppression, can also be reversed by rMuIL-6, as evidenced by epithelialization, granulation tissue formation, and wound closure. In vehicle control mice, rMuIL-6 did not augment healing but rather delayed the process. Immunochemical studies indicated that the expression of matrix metalloproteinase-10 (MMP-10) was increased in dexamethasone-treated mice and that rMuIL-6 treatment reduced its expression, indicating that IL-6 may influence dermal matrix formation and, specifically, collagen synthesis. These results demonstrate that IL-6 can restore abnormal wound repair that occurs in immunodeficiency and suggest its use as a potential therapy.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Immunosuppressive Agents/administration & dosage , Interleukin-6/administration & dosage , Skin/drug effects , Skin/immunology , Wound Healing/drug effects , Wound Healing/immunology , Animals , Cytokines/biosynthesis , Dexamethasone/administration & dosage , Dexamethasone/metabolism , Inflammation/immunology , Inflammation/metabolism , Injections, Subcutaneous , Male , Matrix Metalloproteinase 10 , Metalloendopeptidases/biosynthesis , Mice , Mice, Inbred C57BL , Skin/enzymology
10.
Toxicol Lett ; 120(1-3): 317-21, 2001 Mar 31.
Article in English | MEDLINE | ID: mdl-11323190

ABSTRACT

The liver, which is the major organ responsible for the metabolism of drugs and toxic chemicals, is also the primary target organ for many toxic chemicals. Increasing evidence has indicated that inflammatory processes are intimately involved in chemical-induced hepatotoxic processes, and like other inflammatory diseases, such as autoimmunity, are responsible for producing mediators that can effect liver damage or repair. This review will summarize our current understanding of how inflammatory processes influence hepatic pathology and repair following exposure to established hepatotoxic chemicals including carbon tetrachloride, an industrial chemical, and acetaminophen, a widely used analgesic.


Subject(s)
Inflammation/physiopathology , Liver/drug effects , Animals , Humans , Mice , Proliferating Cell Nuclear Antigen/analysis , Receptors, Tumor Necrosis Factor/physiology , Tumor Necrosis Factor-alpha/physiology
11.
FASEB J ; 14(15): 2525-31, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11099471

ABSTRACT

It has been postulated that an inflammatory response after cutaneous wounding is a prerequisite for healing, and inflammatory cytokines, such as interleukin-6 (IL-6), might be intimately involved in this process. IL-6-deficient transgenic mice (IL-6 KO) displayed significantly delayed cutaneous wound healing compared with wild-type control animals, requiring up to threefold longer to heal. This was characterized by minimal epithelial bridge formation, decreased inflammation, and granulation tissue formation. Using electrophoretic mobility shift assays of wound tissue from IL-6 KO mice, decreased AP-1 transcription factor activation was shown compared with wild-type mice 16 h after wounding. In situ hybridization of wound tissue from wild-type mice revealed IL-6 mRNA expression primarily in the epidermis at the leading edge of the wound. Delayed wound healing in IL-6 KO mice was reversed with a single dose of recombinant murine IL-6 or intradermal injection of an expression plasmid containing the full-length murine IL-6 cDNA. Treatment with rmIL-6 also reconstituted wound healing in dexamethasone-treated immunosuppressed mice. The results of this study may indicate a potential use for IL-6 therapeutically where cutaneous wound healing is impaired.


Subject(s)
Interleukin-6/deficiency , Skin/immunology , Wound Healing/immunology , Animals , CCAAT-Enhancer-Binding Proteins/genetics , DNA-Binding Proteins/genetics , Dexamethasone/pharmacology , Genetic Therapy/methods , Glucocorticoids/pharmacology , Immunosuppression Therapy , Interleukin-6/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , STAT3 Transcription Factor , Trans-Activators/genetics , Transcription Factor AP-1/genetics
12.
Ann N Y Acad Sci ; 919: 214-20, 2000.
Article in English | MEDLINE | ID: mdl-11083111

ABSTRACT

Only recently have toxicologists come to understand the role of inflammation, and TNFalpha specifically, in classical toxicological processes. This relationship appears fairly complex, as inflammation and proliferation may well be only one facet of a time- and dose-dependent continuum of toxicological and repair processes. Not surprisingly, considerable efforts are being undertaken using our newly found understanding of molecular control to develop specific and safe chemical, biological, and molecular regulators of TNFalpha for potential therapeutic use. Their effectiveness in controlling environmental or occupational diseases has yet to be established.


Subject(s)
Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Inflammation/chemically induced , Liver/pathology , Tumor Necrosis Factor-alpha/metabolism , Animals , Carbon Tetrachloride/toxicity , Cell Division , Cells, Cultured , Gene Expression Regulation/drug effects , Liver/drug effects , Liver/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Necrosis , Proliferating Cell Nuclear Antigen/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Tumor Necrosis Factor/genetics , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
13.
Immunopharmacology ; 48(3): 311-3, 2000 Jul 25.
Article in English | MEDLINE | ID: mdl-10960674

ABSTRACT

Immunotoxicology has been defined as the study of adverse effects on the immune system resulting directly from environmental, occupational, or therapeutic exposure to chemicals (including drugs), biological materials and, in certain instances, physiological factors, collectively referred to as agents. It encompasses immunosuppression, allergy, autoimmunity and inflammation.


Subject(s)
Immunotoxins/immunology , Lung/immunology , Respiratory Hypersensitivity/immunology , Animals , Humans , Respiratory Hypersensitivity/diagnosis , Risk Assessment
14.
Alcohol Clin Exp Res ; 24(6): 837-44, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10888072

ABSTRACT

BACKGROUND: Previous studies in our laboratory indicate that alcohol consumption suppresses the metastasis of B16BL6 melanoma, whereas the cytolytic activity of natural killer (NK) cells is decreased in female C57BL/6 mice given 20% w/v alcohol in their drinking water. In the present study, we further evaluated the involvement of NK cells and alcohol consumption in the cytolytic activity of NK cells, the surface expression of NK phenotypic markers, and metastasis of B16BL6 melanoma in C57BL/6 beige (bgJ/bgJ) mutant mice, which possess inherently low NK-cell cytolytic activity. METHODS: Beige and control (bgJ/+) mice were given either water or 20% w/v of alcohol in drinking water for 6 1/2 to 7 weeks before assay for cytolytic activity, surface marker expression, and inoculation with B16BL6 melanoma intravenously or into the pinna of the ear. RESULTS: NK cytolytic activity was suppressed in beige mice, and alcohol consumption did not modulate further the cytolytic activity. Beige mice had a lower percentage of NK cells in the peripheral blood and spleen than control mice. Peripheral blood lymphocytes from beige mice also exhibited a reduced percentage of CD4+ T lymphocytes. Alcohol consumption similarly reduced the percentages of NK1.1- and LGL-1-expressing lymphocytes in the peripheral blood and spleen and reduced the percentage of CD8+ T lymphocytes in the peripheral blood in both control and beige mice. Tumor lung colonization was increased in beige mice relative to control mice after intravenous inoculation of B16BL6 melanoma. The increase was more pronounced in water-drinking beige mice than in control mice irrespective of alcohol consumption. Tumor lung colonization was significantly decreased (p < 0.05) by alcohol consumption in one experiment and partially decreased (p = 0.07) in the other. Mice that were inoculated into the pinna of the ear also exhibited a blunted antimetastatic response to alcohol consumption. CONCLUSIONS: These data suggest that the presence of the beige mutation diminishes the antimetastatic effect of alcohol consumption and that there is no interaction between alcohol consumption and NK-cell activity in the modulation of lung metastasis of B16BL6 melanoma cells.


Subject(s)
Alcohol Drinking/metabolism , Killer Cells, Natural/metabolism , Lung Neoplasms/secondary , Melanoma, Experimental/secondary , Alcohol Drinking/genetics , Animals , Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Female , Killer Cells, Natural/drug effects , Lung Neoplasms/metabolism , Melanoma, Experimental/genetics , Melanoma, Experimental/metabolism , Mice , Mice, Inbred C57BL , Mutation/genetics
15.
J Immunol ; 164(2): 872-8, 2000 Jan 15.
Article in English | MEDLINE | ID: mdl-10623834

ABSTRACT

TNF-alpha is a pleotropic proinflammatory cytokine that has been implicated as a contributing factor in a number of disease processes, primarily through its ability to induce the expression of inflammatory and cytotoxic mediators. TNF-alpha is also involved in cell growth accompanying the healing process in multiple organ systems and influences liver repair following hepatotoxic damage or regeneration following partial hepatectomy. In this respect, TNF-alpha is a known mitogen for hepatocytes. In this paper we describe a novel role for TNF-alpha in the modulation of expression of TGF-alpha, the latter being a complete hepatocyte mitogen. TNF-alpha directly up-regulates TGF-alpha mRNA by up to 7-fold in isolated mouse hepatocytes, whereas neutralization of TNF-alpha significantly decreased liver mRNA and protein expression of TGF-alpha following chemical-induced hepatotoxicity. That TNF-alpha directly stimulated TGF-alpha was suggested by the inability of either anti-IL-6 Abs or cycloheximide to inhibit TNF-alpha-induced TGF-alpha expression in hepatocytes. However, in the presence of anti-TGF-alpha neutralizing Abs, the mitogenic activity of TNF-alpha is abrogated. Using cells transfected with the TGF-alpha promoter, and an RNA polymerase inhibitor, it was shown that TNF-alpha modulates TGF-alpha expression through both pre- and posttranscriptional events. Taken together, these data suggest that TNF-alpha participates in liver repair and regeneration, in part, by directly inducing the expression of TGF-alpha.


Subject(s)
Liver Regeneration/immunology , Liver/immunology , Liver/metabolism , Transforming Growth Factor alpha/biosynthesis , Tumor Necrosis Factor-alpha/physiology , Animals , Carbon Tetrachloride/toxicity , Cell Division/immunology , Cell Line , Cell Separation , Cells, Cultured , Female , Hepatectomy , Interleukin-6/antagonists & inhibitors , Interleukin-6/metabolism , Liver/cytology , Liver/drug effects , Liver Regeneration/genetics , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , RNA, Messenger/biosynthesis , RNA, Messenger/drug effects , Transcription, Genetic , Transforming Growth Factor alpha/genetics , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/immunology
16.
Int J Immunopharmacol ; 22(12): 1143-7, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11137622

ABSTRACT

The liver, which is the major organ responsible for the metabolism of drugs and chemicals, is also the primary target organ for many toxic chemicals. Increasing evidence has indicated that inflammatory processes are intimately involved in chemical-induced hepatotoxic processes, and like other inflammatory diseases, such as autoimmunity, are responsible for producing mediators which can effect liver damage or repair. This review will summarize the authors' current understanding of how inflammatory processes influence hepatic pathology and repair following exposure to established hepatotoxic chemicals including carbon tetrachloride (CCl4), an industrial chemical, and acetaminophen (APAP), a widely used analgesic.


Subject(s)
Chemical and Drug Induced Liver Injury/immunology , Chemical and Drug Induced Liver Injury/pathology , Animals , Humans , Inflammation Mediators/physiology , Necrosis
17.
Crit Rev Toxicol ; 29(5): 491-511, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10521134

ABSTRACT

The molecular cloning of a group of proteins, collectively referred to as cytokines, and including interleukins, chemokines, growth factors, colony stimulating factors, and tumor necrosis factors, has allowed for the increased understanding of the mechanisms for many disease processes as well as provided strategies for the development of novel therapies. Conceptually similar to hormones and peptides, this group of phylogenetically related molecules are also involved in various toxicological processes, including apoptosis, cell repair, and in particular inflammation. In this review, we offer a description of what many believe represents the primary regulatory cytokine, tumor necrosis factor (TNF)alpha and its role in toxicological processes. For over a decade it has been suspected that this molecule helps mediate the shock state induced by bacterial endotoxin and the wasting diathesis that typifies chronic diseases. Advances in molecular biology that have provided tools to modulate TNFalpha regulation and synthesis have allowed for the identification of additional roles for TNFalpha in homeostasis, cellular damage, and repair. This review provides a brief summary of our understanding of TNFalpha biology followed by a discussion of its role in toxicological responses. This is followed by specific examples of organ-specific and tissue-specific responses to chemical damage where TNFalpha has been implicated. The review concludes with a review of its implication in human risk assessment, particularly as it relates to genetic polymorphisms of TNFalpha expression and disease susceptibility.


Subject(s)
Hazardous Substances/toxicity , Toxicology , Tumor Necrosis Factor-alpha/physiology , Animals , Central Nervous System Diseases/chemically induced , Central Nervous System Diseases/metabolism , Chemical and Drug Induced Liver Injury , Humans , Kidney Diseases/chemically induced , Kidney Diseases/metabolism , Liver Diseases/metabolism , Lung Diseases/chemically induced , Lung Diseases/metabolism , Skin Diseases/chemically induced , Skin Diseases/metabolism
18.
Environ Health Perspect ; 107 Suppl 5: 679-80, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10502530

ABSTRACT

Among the issues dealing with identifying potential adverse immunologic effects (i.e., suppression, hypersensitivity, or autoimmunity) associated with xenobiotic exposure, general agreement exists among the regulatory and pharmaceutical communities that predictive tests for autoimmunity are in most need of development in order to improve risk assessment. The estimation of risk (i.e., the probability of a deleterious effect resulting from exposure) involves both the qualitative evaluation of whether a hazard exists and the quantitative evaluation for determining an acceptable level of exposure in humans. Unless adequate human data are available, which is uncommon, this is based on animal studies. Although animal models exist to study autoimmune processes, these models do not readily lend themselves to interpretation in the risk assessment process due, for the most part, to the complexity of autoimmune disease(s), as they are multifactorial and exhibit genetic heterogeneity in humans. To improve the risk assessment process, researchers must develop and validate animal models that not only incorporate mechanistic information into the assessment process but also allow for consideration of potent genetic, physiologic, and environmental influences.


Subject(s)
Autoimmunity , Animals , Autoimmune Diseases/chemically induced , Disease Models, Animal , Environmental Exposure , Environmental Health , Humans , Risk Assessment , Xenobiotics/adverse effects
19.
Gastroenterology ; 117(4): 942-52, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10500078

ABSTRACT

BACKGROUND & AIMS: Tumor necrosis factor (TNF)-alpha is associated with increased mortality in alcoholics, but its role in early alcohol-induced liver injury is not fully understood. Recently, it was shown that injury induced by the enteral alcohol delivery model of Tsukamoto and French was reduced by antibodies to TNF-alpha. To obtain clear evidence for or against the hypothesis that TNF-alpha is involved, we studied TNF receptor 1 (TNF-R1, p55) or 2 (TNF-R2, p75) knockout mice. METHODS: Long-term enteral alcohol delivery was modified for male gene-targeted mice lacking TNF-R1 and TNF-R2. Animals were given a high-fat liquid diet continuously with either ethanol or isocaloric maltose-dextrin as a control for 4 weeks. RESULTS: Ethanol elevated serum levels of alanine aminotransferase nearly 3-fold in wild-type and TNF-R2 knockout mice but not in TNF-R1 knockout mice. Likewise, ethanol caused severe liver injury in wild-type mice (pathology score, 5.5 +/- 0.6) and TNF-R2 knockout mice (pathology score, 5.0 +/- 0.4), but not in TNF-R1 knockout mice (pathology score, 0.8 +/- 0.4; P < 0.001). CONCLUSIONS: Long-term ethanol feeding caused liver injury in wild-type and TNF-R2 knockout mice but not in TNF-R1 knockout mice, providing solid evidence in support of the hypothesis that TNF-alpha plays an important role in the development of early alcohol-induced liver injury via the TNF-R1 pathway. Moreover, the long-term enteral ethanol feeding technique we described for the first time for knockout mice provides a useful new tool for alcohol research.


Subject(s)
Liver Diseases, Alcoholic/physiopathology , Tumor Necrosis Factor-alpha/physiology , Alanine Transaminase/blood , Animals , Body Weight , Cell Movement , Cytokines/genetics , Ethanol/urine , Fatty Liver/etiology , Fatty Liver/pathology , Image Processing, Computer-Assisted , Leukocytes/pathology , Leukocytes/physiology , Liver/pathology , Liver Diseases, Alcoholic/complications , Liver Diseases, Alcoholic/pathology , Liver Diseases, Alcoholic/urine , Male , Mice , Mice, Knockout/genetics , Organ Size , Protein Isoforms/genetics , RNA, Messenger/metabolism , Receptors, Tumor Necrosis Factor/genetics , Tumor Necrosis Factor-alpha/metabolism
20.
Neuropsychology ; 13(2): 291-7, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10353378

ABSTRACT

Writing hand preference is a prominent functional asymmetry, but biomechanical factors may also contribute to any kinematic differences in the quality of handwriting movements performed by either hand. Eighteen dextral participants used a noninking pen with their right or left hand to write cursive letter ls, inverted ls, and their mirror images (to control for biomechanical differences) on a graphics tablet. Kinematic analysis of the scaling, consistency, efficiency, and shape of writing stroke trajectories revealed functional asymmetries between hands. The right hand was faster and produced more efficient strokes, which were of more consistent length, duration, and peak velocity. Differences between hands do not simply reflect biomechanical factors; therefore, the documentation of any functional asymmetries may allow their subsequent use as markers of underlying pathology in conditions such as schizophrenia.


Subject(s)
Functional Laterality , Handwriting , Movement/physiology , Adolescent , Adult , Biomechanical Phenomena , Cross-Over Studies , Female , Humans , Kinetics , Male , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...